Amiksin - instructions for use, analogs, reviews and release forms (60 mg and 125 mg tablets) for the treatment and prevention of influenza, ARVI, herpes and hepatitis in adults, children and pregnancy
In this article, you can read the instructions for using the drug Amiksin. There are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors specialists on the use of Amiksin in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Amiksin in the presence of existing structural analogues. Use for the treatment and prevention of influenza, SARS, herpes and hepatitis in adults, children, as well as during pregnancy and lactation.
Amiksin - a low-molecular synthetic Interferon inducer, which stimulates the formation of alpha, beta, and gamma interferons in the body. The main structures that produce interferon in response to the administration of tylorone (Amixin's drug substance) are intestinal epithelial cells, hepatocytes, T-lymphocytes, neutrophils and granulocytes. After taking the drug inside, the maximum production of interferon is determined in the intestine-liver-blood sequence after 4-24 hours. Amiksin has an immunomodulatory and antiviral effect.
In human leukocytes induces the synthesis of interferon. Stimulates bone marrow stem cells, depending on the dose, enhances antibody formation, reduces the degree of immunosuppression, restores the ratio of T-suppressors and T-helpers. Effective with various viral infections (including those caused by viruses of the flu, other pathogens of acute respiratory viral infections, hepatitis viruses, herpes). The mechanism of antiviral action is associated with the inhibition of the translation of virus-specific proteins in infected cells, as a result of which the reproduction of viruses is suppressed.
Pharmacokinetics
After taking the drug inside Amiksin quickly absorbed from the digestive tract.Tyloron does not undergo biotransformation and does not accumulate in the body. It is excreted almost unchanged with feces (about 70%) and urine (about 9%).
Indications
In adults
- for the prevention and treatment of influenza and ARVI;
- for the treatment of viral hepatitis A, B and C;
- for the treatment of herpetic infection;
- for the treatment of cytomegalovirus infection;
- as part of complex therapy of allergic and viral encephalomyelitis (including multiple sclerosis, leukoencephalitis, uveoencephalitis);
- in the complex therapy of urogenital and respiratory chlamydia;
- as part of a comprehensive therapy for pulmonary tuberculosis.
In children older than 7 years
- for treatment of influenza and ARVI.
Forms of release
Tablets coated with 60 mg and 125 mg.
Instructions for use and dosage
The drug is taken orally after a meal.
In adults, for non-specific prophylaxis of viral hepatitis A, the drug is administered at a dose of 125 mg once a week for 6 weeks. The course dose is 750 mg (6 tablets).
In the treatment of viral hepatitis A, the dose of the drug on the first day is 125 mg twice a day, then go on to receive 125 mg after 48 hours. The course of treatment is 1.25 g (10 tablets).
When treating acute hepatitis B in the initial phase of treatment on the first and second day, the dose is 125 mg per day, and then 125 mg after 48 hours. The course of treatment is 2 g (16 tablets).
With prolonged hepatitis B in the first day, the dose is 125 mg twice a day, then 125 mg after 48 hours. The course dose is 2.5 g (20 tablets).
In chronic hepatitis B in the initial phase of treatment, the total dose is 2.5 g (20 tablets). In the first 2 days, the daily dose of 250 mg, then go to receive 125 mg after 48 hours. In the continuation phase of treatment, the total dose is from 1.25 g (10 tablets) to 2.5 g (20 tablets), with the drug administered at a dose of 125 mg in a week. The course dose of Amixin varies from 3.75 to 5 g, the duration of treatment is 3.5-6 months, depending on the results of biochemical, immunological and morphological studies, reflecting the degree of activity of the process.
In acute hepatitis C on the first and second day of treatment, Amiksin is prescribed at a dose of 125 mg per day, then 125 mg after 48 hours. The course dose is 2.5 g (20 tablets).
In chronic hepatitis C in the initial phase of treatment, the total dose is 2.5 g (20 tablets). In the first 2 days, the drug is taken at a dose of 250 mg per day, then 125 mg after 48 hours. In the continuation phase, the total dose is 2.5 g (20 tablets), with the drug administered at a dose of 125 mg per week. The course dose of Amiksin is 5 g (40 tablets), the duration of treatment is 6 months depending on the results of biochemical,immunological and morphological studies reflecting the degree of activity of the process.
In the complex treatment of neuroviral infections - 125-250 mg per day in the first two days of treatment, then 125 mg at 48 hours. The dose is set individually, the duration of the course of treatment is 3-4 weeks.
For treatment of influenza and other acute respiratory viral infections in the first 2 days of the disease, Amiksin is prescribed at a dose of 125 mg per day, then 125 mg after 48 hours. The course dose is 750 mg (6 tablets).
For the prevention of influenza and SARS, Amixin is prescribed in a dose of 125 mg once a week for 6 weeks. The course dose is 750 mg (6 tablets).
To treat herpetic, cytomegalovirus infection, the dose of the drug in the first 2 days is 125 mg, then take 125 mg after 48 hours. The course dose is 1.25-2.5 g (10-20 tablets).
With urogenital and respiratory chlamydia, Amixin is prescribed at a dose of 125 mg per day for the first 2 days, then 125 mg after 48 hours. The course dose is 1.25 g (10 tablets).
In the complex therapy of pulmonary tuberculosis in the first 2 days, the drug is prescribed 250 mg per day, then 125 mg at 48 hours. The course dose is 2.5 g (20 tablets).
Children older than 7 years with uncomplicated forms of influenza or other acute respiratory viral infections are prescribed a dose of 60 mg (1 tablet) once a day after meals on the 1st, 2nd and 4th days after the start of treatment.The course dose is 180 mg (3 tablets).
With the development of complications of influenza and other acute respiratory viral infections, the drug is taken 60 mg once a day on the 1 st, 2 nd, 4 th, 6 th days from the start of treatment. The course dose is 240 mg (4 tablets).
Side effect
- dyspepsia;
- short-term chill;
- allergic reactions.
Contraindications
- pregnancy;
- the period of breastfeeding;
- children's age till 7 years;
- hypersensitivity to the drug.
Application in pregnancy and lactation
Amiksin is contraindicated for use during pregnancy and during breastfeeding.
special instructions
Amixin is compatible with antibiotics and traditional means of treatment of viral and bacterial infections.
Drug Interactions
Clinically significant drug interaction of Amiksin with antibiotics and traditional treatment of viral and bacterial infections was not detected.
Analogues of the drug Amiksin
Structural analogs for the active substance:
- Lavomax;
- Thilaxin;
- Tyloron.
Similar medicines:
Other medicines:
- Lactofiltrum - instructions for use, reviews, analogs and forms of release (tablets) of a drug for the treatment of diarrhea and allergies in adults, children and pregnancy. Composition and action
- Naise - instructions for use, reviews, analogs and formulations (50 mg and 100 mg tablets, 1% gel, suspension or syrup) drugs for the treatment of pain and inflammation in joints and muscles in adults, children and in pregnancy
- Protargol - instructions for use, reviews, analogs and formulations (drops in the nose 1% and 2%) of the drug for the treatment of common cold and adenoids in adults, children (including babies and newborns) and in pregnancy